Richard Newitter
Stock Analyst at Truist Securities
(3.85)
# 627
Out of 5,173 analysts
457
Total ratings
47.83%
Success rate
9.15%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Upgrades: Buy | $27 → $35 | $25.09 | +39.50% | 6 | Mar 19, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $95 → $92 | $69.54 | +32.30% | 22 | Mar 18, 2026 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $47 → $30 | $26.02 | +15.30% | 17 | Mar 2, 2026 | |
| KIDS OrthoPediatrics | Maintains: Hold | $19 → $20 | $16.47 | +21.43% | 11 | Mar 2, 2026 | |
| LNTH Lantheus Holdings | Maintains: Buy | $82 → $89 | $75.73 | +17.52% | 23 | Mar 2, 2026 | |
| SIBN SI-BONE | Reiterates: Buy | $23 → $24 | $12.99 | +84.76% | 2 | Feb 24, 2026 | |
| IRTC iRhythm Holdings | Reiterates: Buy | $215 → $200 | $118.14 | +69.29% | 20 | Feb 23, 2026 | |
| ITGR Integer Holdings | Maintains: Buy | $95 → $97 | $85.33 | +13.68% | 13 | Feb 20, 2026 | |
| PODD Insulet | Maintains: Buy | $390 → $360 | $227.08 | +58.53% | 5 | Feb 19, 2026 | |
| DXCM DexCom | Reiterates: Buy | $82 → $80 | $65.94 | +21.32% | 4 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $96 → $70 | $52.16 | +34.20% | 31 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $92 → $89 | $82.02 | +8.51% | 23 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $25 | $11.02 | +126.86% | 6 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $370 → $374 | $335.56 | +11.46% | 8 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $32.45 | +38.67% | 6 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $4 → $3 | $1.26 | +138.10% | 19 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $400 → $392 | $332.59 | +17.86% | 25 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $110 → $107 | $87.17 | +22.75% | 19 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $620 → $650 | $478.04 | +35.97% | 32 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $145 | $106.84 | +35.72% | 7 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $93 → $105 | $87.21 | +20.40% | 30 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 → $20 | $10.40 | +92.31% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $15 | $9.43 | +59.07% | 19 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $137 | $105.85 | +29.43% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $87.80 | +28.70% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $6.39 | +212.99% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $74.14 | +10.60% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $156.23 | +60.02% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $2.47 | +954.77% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $180.86 | +325.74% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $75.64 | +12.37% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $6.07 | +229.49% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $31.75 | -14.96% | 5 | Feb 23, 2021 |
Tandem Diabetes Care
Mar 19, 2026
Upgrades: Buy
Price Target: $27 → $35
Current: $25.09
Upside: +39.50%
Boston Scientific
Mar 18, 2026
Maintains: Buy
Price Target: $95 → $92
Current: $69.54
Upside: +32.30%
PROCEPT BioRobotics
Mar 2, 2026
Maintains: Buy
Price Target: $47 → $30
Current: $26.02
Upside: +15.30%
OrthoPediatrics
Mar 2, 2026
Maintains: Hold
Price Target: $19 → $20
Current: $16.47
Upside: +21.43%
Lantheus Holdings
Mar 2, 2026
Maintains: Buy
Price Target: $82 → $89
Current: $75.73
Upside: +17.52%
SI-BONE
Feb 24, 2026
Reiterates: Buy
Price Target: $23 → $24
Current: $12.99
Upside: +84.76%
iRhythm Holdings
Feb 23, 2026
Reiterates: Buy
Price Target: $215 → $200
Current: $118.14
Upside: +69.29%
Integer Holdings
Feb 20, 2026
Maintains: Buy
Price Target: $95 → $97
Current: $85.33
Upside: +13.68%
Insulet
Feb 19, 2026
Maintains: Buy
Price Target: $390 → $360
Current: $227.08
Upside: +58.53%
DexCom
Feb 17, 2026
Reiterates: Buy
Price Target: $82 → $80
Current: $65.94
Upside: +21.32%
Feb 12, 2026
Maintains: Hold
Price Target: $96 → $70
Current: $52.16
Upside: +34.20%
Feb 11, 2026
Maintains: Hold
Price Target: $92 → $89
Current: $82.02
Upside: +8.51%
Feb 2, 2026
Maintains: Buy
Price Target: $37 → $25
Current: $11.02
Upside: +126.86%
Jan 16, 2026
Downgrades: Hold
Price Target: $370 → $374
Current: $335.56
Upside: +11.46%
Dec 18, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $32.45
Upside: +38.67%
Dec 18, 2025
Maintains: Hold
Price Target: $4 → $3
Current: $1.26
Upside: +138.10%
Dec 18, 2025
Maintains: Hold
Price Target: $400 → $392
Current: $332.59
Upside: +17.86%
Dec 18, 2025
Maintains: Hold
Price Target: $110 → $107
Current: $87.17
Upside: +22.75%
Dec 18, 2025
Maintains: Buy
Price Target: $620 → $650
Current: $478.04
Upside: +35.97%
Dec 18, 2025
Maintains: Buy
Price Target: $120 → $145
Current: $106.84
Upside: +35.72%
Nov 18, 2025
Reiterates: Buy
Price Target: $93 → $105
Current: $87.21
Upside: +20.40%
Nov 7, 2025
Reiterates: Buy
Price Target: $18 → $20
Current: $10.40
Upside: +92.31%
Oct 15, 2025
Maintains: Hold
Price Target: $13 → $15
Current: $9.43
Upside: +59.07%
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $105.85
Upside: +29.43%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $87.80
Upside: +28.70%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $6.39
Upside: +212.99%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $74.14
Upside: +10.60%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $156.23
Upside: +60.02%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $2.47
Upside: +954.77%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $180.86
Upside: +325.74%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $75.64
Upside: +12.37%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $6.07
Upside: +229.49%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $31.75
Upside: -14.96%